These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 32697327)

  • 1. Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV).
    Bekker A; Decloedt EH; Slade G; Cotton MF; Rabie H; Cressey TR
    Clin Infect Dis; 2021 Jun; 72(11):2032-2034. PubMed ID: 32697327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.
    Bekker A; Capparelli EV; Violari A; Cotton MF; Cababasay M; Wang J; Mathiba R; Wiesner L; Wiznia A; Samson P; Browning R; Moye J; Nakwa FL; Decloedt E; Rabie H; Mirochnick M; Cressey TR;
    Lancet HIV; 2022 Jan; 9(1):e24-e31. PubMed ID: 34883066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.
    Kline MW; Blanchard S; Fletcher CV; Shenep JL; McKinney RE; Brundage RC; Culnane M; Van Dyke RB; Dankner WM; Kovacs A; McDowell JA; Hetherington S
    Pediatrics; 1999 Apr; 103(4):e47. PubMed ID: 10103339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
    Kessler HA; Johnson J; Follansbee S; Sension MG; Mildvan D; Sepulveda GE; Bellos NC; Hetherington SV
    Clin Infect Dis; 2002 Feb; 34(4):535-42. PubMed ID: 11797183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis.
    Adetokunboh OO; Schoonees A; Balogun TA; Wiysonge CS
    BMC Infect Dis; 2015 Oct; 15():469. PubMed ID: 26502899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus-infected children in relation to treatment outcomes.
    Archary M; Mcllleron H; Bobat R; LaRussa P; Sibaya T; Wiesner L; Hennig S
    Br J Clin Pharmacol; 2019 Sep; 85(9):2066-2075. PubMed ID: 31141195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH; Chittick GE; McDowell JA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects.
    Weller S; Radomski KM; Lou Y; Stein DS
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2052-60. PubMed ID: 10898675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertigo and abacavir.
    Fantry LE; Staecker H
    AIDS Patient Care STDS; 2002 Jan; 16(1):5-7. PubMed ID: 11839213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
    Ruane P; Lang J; DeJesus E; Berger DS; Dretler R; Rodriguez A; Ward DJ; Lim ML; Liao Q; Reddy S; Clair MS; Vila T; Shaefer MS
    HIV Clin Trials; 2006; 7(5):229-36. PubMed ID: 17162316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir and lamivudine for the treatment of human immunodeficiency virus.
    Rizzardini G; Zucchi P
    Expert Opin Pharmacother; 2011 Sep; 12(13):2129-38. PubMed ID: 21787242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
    Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
    JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus.
    Schafer JJ; Short WR; Squires KE
    Pharmacotherapy; 2010 Oct; 30(10):1072-83. PubMed ID: 20874044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abacavir-based Regimen for HIV-infected Children and Adolescents.
    Pareek P; Singh DK; Rai R; Srivastava A; Maurya M
    Indian Pediatr; 2019 Aug; 56(8):685-686. PubMed ID: 31477651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abacavir update.
    Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.
    van Praag RM; van Heeswijk RP; Jurriaans S; Lange JM; Hoetelmans RM; Prins JM
    Clin Infect Dis; 2001 Oct; 33(8):e91-2. PubMed ID: 11565093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abacavir for children and adults.
    Treat Rev; 1997 Nov; (No 26-27):10-1. PubMed ID: 11364930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis.
    Michienzi SM; Schriever CA; Badowski ME
    Int J STD AIDS; 2019 Feb; 30(2):181-187. PubMed ID: 30381029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approves abacavir. Food and Drug Administration.
    Highleyman L
    BETA; 1999 Jan; 12(1):3. PubMed ID: 11367235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.